Notice2023-03511
National Cancer Institute; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 21, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 34 (Tuesday, February 21, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 34 (Tuesday, February 21, 2023)]
[Notices]
[Pages 10528-10529]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-03511]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Frederick National
Laboratory Advisory Committee to the National Cancer Institute.
The meeting will be held virtually and is open to the public.
Individuals who plan to view the virtual meeting and need special
assistance or other reasonable accommodations to view the meeting,
should notify the Contact Person listed below in advance of the
meeting. The meeting will be videocast and can be accessed from the NIH
Videocasting and Podcasting website (<a href="http://videocast.nih.gov">http://videocast.nih.gov</a>).
Name of Committee: Frederick National Laboratory Advisory
Committee to the National Cancer Institute.
Date: February 27, 2023.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: Ongoing and new activities at the Frederick National
Laboratory for Cancer Research.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Rockville, MD 20850 (Virtual Meeting).
Contact Person: Wlodek Lopaczynski, M.D., Ph.D., Assistant
Director, Office of the Director, Division of Extramural Activities,
National Cancer Institute, National Institutes of Health, 9609
Medical Center Drive, Seventh Floor, West Tower, Room 7W514,
Bethesda, MD 20892, (240) 276-6458, <a href="/cdn-cgi/l/email-protection#117d7e61707266517c70787d3f7f78793f767e67"><span class="__cf_email__" data-cfemail="0f63607f6e6c784f626e66632161666721686079">[email protected]</span></a>.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: FNLAC: <a href="https://deainfo.nci.nih.gov/advisory/fac/fac.htm">https://deainfo.nci.nih.gov/advisory/fac/fac.htm</a>, where
an agenda and any additional information for the meeting will be
posted when available.
This notice is being published less than 15 days prior to the
meeting due to scheduling difficulties.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399,
[[Page 10529]]
Cancer Control, National Institutes of Health, HHS)
Dated: February 15, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-03511 Filed 2-17-23; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 21, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.